Antibe Therapeutics Inc
F:4B70
Antibe Therapeutics Inc
F:4B70
Price:
0.188
EUR
Market Cap:
€9.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Antibe Therapeutics Inc
F:4B70
|
CA |
|
Western Sierra Resource Corp
OTC:WSRC
|
US |
|
GeoVax Labs Inc
F:E8L
|
US |
|
SPAR Group Inc
F:PMH
|
US |
|
C
|
Clean Seas Seafood Ltd
F:C7S
|
AU |
|
Simclar Inc
OTC:SIMC
|
US |
|
Compagnie des Alpes SA
F:JCA
|
FR |
|
C
|
Curis Inc
F:CUSA
|
US |
|
C
|
C3 Metals Inc
OTC:CUAUF
|
CA |
|
C
|
Clarkson PLC
F:1DH
|
UK |
|
D
|
Dormakaba Holding AG
XMUN:KABN
|
CH |
|
Mechel PAO
MOEX:MTLRP
|
RU |
|
WellQuest Medical & Wellness Corp
OTC:WEQL
|
US |
|
M
|
Mountain Province Diamonds Inc
F:MPG
|
CA |
|
Pershing Resources Company Inc
OTC:PSGR
|
US |
|
RoodMicrotec N.V.
F:ROO
|
NL |
|
BeMetals Corp
F:1OI
|
CA |
|
E
|
East Africa Metals Inc
F:EA1
|
CA |
|
G
|
Gossamer Bio Inc
F:4GB
|
US |
Intrinsic Value
Not Available for 4B70
There is not enough data to reliably calculate the intrinsic value for Antibe Therapeutics Inc.
Do our valuations actually work? See backtest results .
Alternatives to 4B70
Fundamental Analysis
Financials
Revenue & Expenses Breakdown
Antibe Therapeutics Inc
Antibe Therapeutics Inc
Efficiency
Earnings Waterfall
Antibe Therapeutics Inc
Antibe Therapeutics Inc
